NYSE:NTRNutrien Stock Price, Forecast & News

Nutrien's stock was trading at $32.00 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, NTR shares have increased by 20.3% and is now trading at $38.51.
View which stocks have been most impacted by COVID-19.

22 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nutrien in the last year. There are currently 6 hold ratings, 15 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Nutrien.

Nutrien is scheduled to release its next quarterly earnings announcement on Monday, November 2nd 2020.
View our earnings forecast for Nutrien.

Nutrien Ltd (NYSE:NTR) announced its earnings results on Monday, August, 10th. The company reported $1.45 earnings per share for the quarter, beating the Zacks' consensus estimate of $1.37 by $0.08. The company had revenue of $8.42 billion for the quarter, compared to the consensus estimate of $8.32 billion. Nutrien had a return on equity of 4.66% and a net margin of 4.49%. Nutrien's revenue was down 3.2% on a year-over-year basis. During the same period in the prior year, the firm earned $1.58 earnings per share.
View Nutrien's earnings history.

Nutrien declared a quarterly dividend on Monday, August 10th. Stockholders of record on Wednesday, September 30th will be paid a dividend of $0.45 per share on Friday, October 16th. This represents a $1.80 annualized dividend and a yield of 4.67%. The ex-dividend date is Tuesday, September 29th.
View Nutrien's dividend history.

Nutrien updated its FY20 earnings guidance on Monday, August, 10th. The company provided earnings per share guidance of $1.50-1.90 for the period, compared to the Thomson Reuters consensus estimate of $1.62.

22 analysts have issued 1 year price objectives for Nutrien's shares. Their forecasts range from $36.00 to $70.00. On average, they expect Nutrien's stock price to reach $49.05 in the next twelve months. This suggests a possible upside of 27.4% from the stock's current price.
View analysts' price targets for Nutrien.

News coverage about NTR stock has been trending negative recently, according to InfoTrie. InfoTrie identifies negative and positive news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Nutrien earned a coverage optimism score of -2.4 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the next several days.
View the latest news about Nutrien.

Nutrien saw a drop in short interest during the month of April. As of April 30th, there was short interest totaling 3,280,000 shares, a drop of 22.3% from the April 15th total of 4,220,000 shares. Based on an average daily volume of 2,200,000 shares, the short-interest ratio is currently 1.5 days. Currently, 0.6% of the company's shares are short sold.
View Nutrien's Short Interest.

Some companies that are related to Nutrien include Scotts Miracle-Gro (SMG), CF Industries (CF), Mosaic (MOS), ICL Group (ICL), Nufarm (NUF), American Vanguard (AVD), Calyxt (CLXT), Marrone Bio Innovations (MBII), CVR Partners (UAN), Wynnstay Group (WYN), Arcadia Biosciences (RKDA), Evogene (EVGN), Eden Research (EDEN), China Green Agriculture (CGA) and Bion Environmental Technologies (BNET).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Nutrien investors own include AT&T (T), Bank of America (BAC), General Electric (GE), Pfizer (PFE), Intel (INTC), Johnson & Johnson (JNJ), Micron Technology (MU), AbbVie (ABBV), JPMorgan Chase & Co. (JPM) and NVIDIA (NVDA).

Nutrien trades on the New York Stock Exchange (NYSE) under the ticker symbol "NTR."

Nutrien's stock is owned by many different retail and institutional investors. Top institutional investors include First Eagle Investment Management LLC (4.05%), Jarislowsky Fraser Ltd (2.37%), TD Asset Management Inc. (1.83%), CIBC Asset Management Inc (1.49%), Black Creek Investment Management Inc. (1.47%) and FMR LLC (1.39%).

NTR stock was sold by a variety of institutional investors in the last quarter, including Toronto Dominion Bank, FMR LLC, Tocqueville Asset Management L.P., Hexavest Inc., Addenda Capital Inc., Cambiar Investors LLC, Bank of Nova Scotia, and Intact Investment Management Inc..

NTR stock was acquired by a variety of institutional investors in the last quarter, including ARGA Investment Management LP, TD Asset Management Inc., QV Investors Inc., BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp, CIBC Asset Management Inc, First Eagle Investment Management LLC, Jarislowsky Fraser Ltd, and Grantham Mayo Van Otterloo & Co. LLC.

Shares of NTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of NTR stock can currently be purchased for approximately $38.51.

Nutrien has a market capitalization of $21.92 billion and generates $20.02 billion in revenue each year. The company earns $992 million in net income (profit) each year or $2.17 on an earnings per share basis. Nutrien employs 22,300 workers across the globe.

The official website for Nutrien is www.nutrien.com.

Nutrien's mailing address is SUITE 500 122 - 1ST AVENUE SOUTH, SASKATOON A9, S7K 7G3. The company can be reached via phone at 306-933-8500 or via email at [email protected]